Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO Chamber

Pranlukast (PLK) is a leukotriene receptor antagonist (LTRA) that has been approved for treatment of asthma in patients of all ages and allergic rhinitis (AR) in adults but not for AR in children in Japan. This randomized, double-blind, placebo-controlled, crossover study used an artificial exposure...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Allergy and asthma proceedings 2012-01, Vol.33 (1), p.102-109
Hauptverfasser:	Wakabayashi, Ken-ichiro, Hashiguchi, Kazuhiro, Kanzaki, Sho, Fujioka, Masato, Tanaka, Nobuaki, Kawashima, Kayoko, Suematsu, Kiyochika, Yamamotoya, Hajime, Iwasaki, Manabu, Gotoh, Minoru, Horibe, Seiji, Naito, Kensei, Okubo, Kimihiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adolescent Allergens - adverse effects Allergens - immunology Artificial Exposure Chamber Atmosphere Exposure Chambers - utilization Child Children Chromones - administration & dosage Chromones - adverse effects Cryptomeria - immunology Double-Blind Female Humans Immunization Japanese Cedar Pollinosis Leukotriene Antagonists - administration & dosage Leukotriene Antagonists - adverse effects Leukotriene Receptor Antagonist Male Nasal Obstruction Nasal Obstruction - drug therapy Nasal Obstruction - etiology Ohio Chamber Placebo-Controlled Pollen - adverse effects Pranlukast Rhinitis, Allergic, Seasonal - complications Rhinitis, Allergic, Seasonal - drug therapy Seasonal Allergic Rhinitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!